Cargando…
Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
Historical, the non-small cell lung cancer (NSCLC) was as a united disease entity and the chemotherapy to the metastatic cancer had limited results. Recent studies for the metastatic non-small cell lung cancer led to the ascertainment that the NSCLC does not constitute exclusively a disease entity,...
Autores principales: | Lampaki, Sofia, Lazaridis, George, Zarogoulidis, Konstantinos, Kioumis, Ioannis, Papaiwannou, Antonis, Tsirgogianni, Katerina, Karavergou, Anastasia, Tsiouda, Theodora, Karavasilis, Vasilis, Yarmus, Lonny, Darwiche, Kaid, Freitag, Lutz, Sakkas, Antonios, Kantzeli, Angeliki, Baka, Sofia, Hohenforst-Schmidt, Wolfgang, Zarogoulidis, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439943/ https://www.ncbi.nlm.nih.gov/pubmed/26000049 http://dx.doi.org/10.7150/jca.11893 |
Ejemplares similares
-
Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?
por: Domvri, Kalliopi, et al.
Publicado: (2015) -
Interleukin-7 and Interleukin-15 for Cancer
por: Zarogoulidis, Paul, et al.
Publicado: (2014) -
Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy
por: Domvri, Kalliopi, et al.
Publicado: (2013) -
A gene therapy induced emphysema model and the protective role of stem cells
por: Zarogoulidis, Paul, et al.
Publicado: (2014) -
Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis
por: Zarogoulidis, Paul, et al.
Publicado: (2013)